ArticleBiomolecules2023

Engineering of a Bispecific Nanofitin with Immune Checkpoint Inhibitory Activity Conditioned by the Cross-Arm Binding to EGFR and PDL1.

Perrine Jacquot et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.